Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP535244.RAg7MRwiQ2-jt3x0nnXxjboVLT_pBpq9QmXvw7yWNUnu4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP535244.RAg7MRwiQ2-jt3x0nnXxjboVLT_pBpq9QmXvw7yWNUnu4130_assertion type Assertion NP535244.RAg7MRwiQ2-jt3x0nnXxjboVLT_pBpq9QmXvw7yWNUnu4130_head.
- NP535244.RAg7MRwiQ2-jt3x0nnXxjboVLT_pBpq9QmXvw7yWNUnu4130_assertion description "[Antagonists of the effect of lung cancer-derived galectin-1 on DCs and anti-HB-EGF blocking antibodies could, therefore, have therapeutic potential as antitumor agents.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535244.RAg7MRwiQ2-jt3x0nnXxjboVLT_pBpq9QmXvw7yWNUnu4130_provenance.
- NP535244.RAg7MRwiQ2-jt3x0nnXxjboVLT_pBpq9QmXvw7yWNUnu4130_assertion evidence source_evidence_literature NP535244.RAg7MRwiQ2-jt3x0nnXxjboVLT_pBpq9QmXvw7yWNUnu4130_provenance.
- NP535244.RAg7MRwiQ2-jt3x0nnXxjboVLT_pBpq9QmXvw7yWNUnu4130_assertion SIO_000772 22291012 NP535244.RAg7MRwiQ2-jt3x0nnXxjboVLT_pBpq9QmXvw7yWNUnu4130_provenance.
- NP535244.RAg7MRwiQ2-jt3x0nnXxjboVLT_pBpq9QmXvw7yWNUnu4130_assertion wasDerivedFrom befree-20150227 NP535244.RAg7MRwiQ2-jt3x0nnXxjboVLT_pBpq9QmXvw7yWNUnu4130_provenance.
- NP535244.RAg7MRwiQ2-jt3x0nnXxjboVLT_pBpq9QmXvw7yWNUnu4130_assertion wasGeneratedBy ECO_0000203 NP535244.RAg7MRwiQ2-jt3x0nnXxjboVLT_pBpq9QmXvw7yWNUnu4130_provenance.